Detecting HEK293 residual DNA contamination in your cell or gene therapy products

Published: 7 June 2023

Infographic

Cell and gene therapies begin their development with the help of a host cell line. However, all trace of the host cell DNA must be removed before the product can be administered to a patient to avoid oncogenic effects.

This infographic illustrates how you can detect with precision HEK293 residual DNA contamination in cell and gene therapy products by using Bio-Rad ddPCR technology.

This infographic illustrates how you can be confident in detecting HEK293 residual DNA contamination in cell and gene therapy products by using BIO-RAD solutions.

Detecting HEK293 residual DNA contamination in your cell or gene therapy products

Cell and gene therapies begin their development with the help of a host cell line. However, all trace of the host cell DNA must be removed before the product can be administered to a patient to avoid oncogenic effects. ﻿﻿

Cell and gene therapies begin their development with the help of a host cell line. However, all trace of the host cell DNA must be removed before the product can be administered to a patient to avoid oncogenic effects.